Johnson & Johnson Stock Jumps 3% as Healthcare Rotation Lifts Shares
This article first appeared on GuruFocus. Johnson & Johnson (NYSE:JNJ), the healthcare heavyweight behind blockbuster medicines and medical…
Scoop: Johnson & Johnson to Lead Delix Therapeutics’ $85M Series C
Delix Therapeutics was the first well-funded ‘non-hallucinogenic psychedelic’ drug developer to emerge, in many ways defining the category.…
Mayo Clinic hires Honeywell Aerospace alumnus as new CIO – Post Bulletin
ROCHESTER — Mayo Clinic has hired Arun Kumar Bhaskara-Baba as its new chief information officer, filling a position…
Inside the rare, 11-hour operation to remove 7kg tumour from man’s neck
Play Brightcove video ITV News Reporter Ellie Pitt was given exclusive access to film an unprecedented and extraordinary…
Dartmouth Health says it needs to close some telehealth services
Dartmouth Health expects to end its Tele-ICU and Tele-ED services, a move that would affect five Vermont hospitals…
Gilead Sciences Has Quietly Become One of the Most Underrated Turnaround Stories in Healthcare. Here’s Why Wall Street Is Excited.
Gilead Sciences (GILD +3.25%) has shifted from a period of stagnant growth, driven by slowing hepatitis C revenues…
R1 to Acquire Humata Health, Enhancing Phare OS with
CHICAGO, Aug. 18, 2026 (GLOBE NEWSWIRE) — R1 (“R1” or the “Company”), an industry leader in healthcare revenue…
What happens when your hospital is also your insurance company? We’re starting to see the effects
Historically, hospitals have provided care for people, while separate insurers have paid for that care. During the past…
World Humanitarian Day 2026: honouring fallen humanitarians and calling for greater protection of health care
As we mark World Humanitarian Day on 19 August, WHO pays tribute to humanitarian and health workers who…
After a layoff and long job search, this 45-year-old is going to nursing school
Kristy Layden was tired of opening LinkedIn and seeing one person after another post about being laid off…
BioMarin to Acquire Alesta Therapeutics to Gain ALE1, a Potential First Oral Therapy for Hypophosphatasia, Adding an Important Clinical Program to BioMarin’s Pipeline
BioMarin to pay $275 million upfront, plus additional payments upon achievement of development and regulatory milestones Alesta to…
One in seven are using AI instead of a GP
Rather than discussing whether AI should be used for health advice, all efforts should focus on ensuring the…